News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agreed, just a matter of time imo
The level of interest in the BCI space is growing exponentially.
Looking at the EXPO 24 material, quality of speakers, and industry participation, I believe the company is setting up to be an important component in this field.
Outstanding management and technology. Share structure is tight.
Elon Musk's Neuralink Prepares For Second Human Trial, Aims 'Superpower' Capabilities
"Neuralink plans to implant its device into a second human patient in about a week, according to the company’s founder, Elon Musk. During a broadcast on the social media platform X (formerly Twitter), Musk shared that the company aims to have ‘high single digits’ of patients with the device by the end of the year. He and several Neuralink executives discussed the brain chip’s capabilities and future potential, such as treating paralysis and memory loss. They also addressed improvements for future surgeries to prevent issues encountered during the first implantation on Arizona man Noland Arbaugh. Musk emphasised that the long-term goal is to reduce the civilisational risk posed by AI by fostering “a closer symbiosis between human intelligence and digital intelligence.”
Elon Musk stated that the goal is “to give people superpowers,” as he announced that Neuralink will implement changes to address the issue of its electrode threads retracting from brain tissue in upcoming surgeries. To mitigate this problem, the proposed fixes include removing an air pocket that may have caused the threads to retract in the first surgery. Additionally, the company plans to insert the threads more accurately on the folds of the brain in future procedures, he explained.
Earlier in January, Neuralink successfully transplanted the device into the brain of a man who was paralysed from the shoulders down in a diving accident. After the implantation of Neuralink, the man was able to play chess, and video games and control the computer screen with his brain. Elon Musk has a strong passion for technology and constantly seeks to innovate in the field. Neuralink is a product of this mindset. The company, specialising in neural interface technology, is gaining attention for its unique chip. Neuralink has developed an AI-powered microchip capable of recording and interpreting brain activity. Remarkably, this chip is designed to help individuals overcome mental disabilities. The company asserts that the chip can even read your thoughts."
No doubt it's time has come with AI revolution
Elon Musk's Neuralink progress should positively affect others in the space such as Neuraseed under the leadership of Neilank K. Jha, MD, FRCS(C), MSc, MBA. CEO of Neuraseed.
Elon Musk's Neuralink Prepares For Second Human Trial, Aims 'Superpower' Capabilities: https://www.news18.com/business/elon-musks-neuralink-prepares-for-second-human-trial-aims-superpower-capabilities-8961904.html
An interesting behind-the-scenes look at Neuralink.
https://www.msn.com/en-us/health/other/ar-BB1pKYYa
The NeuraSeed BCI Expo 2024 is scheduled for August 2nd. The resulting outcome should provide significant positive exposure and position the company to share its plans with the investment community.
The conference attendees are leaders in the industry. Excellent exposure.
Czech~OUTT BWVI's spiffy corporate presentation at the link below:
Yup, Capn Keith the retired hobby diver and Zappy/Zippy are breathing nitrous oxide at 150 foot depth to bring up the psychedelic mushroom juice from the wreck of the Pulaski.
Love it when a solid plan comes together in subpennyland!
Company's continued inability to undertake certain corporate actions (name and symbol change, M&A, Reverse Split etc.) due to uncorrectable regulatory filing deficiencies from over a decade ago has remained a significant and overwhelming ongoing challenge to the Company.
Companies in similar situations generally become insolvent and have no choice but to file for bankruptcy. However, the Company is doing everything to avert this outcome.
$BWVI: May 16, 2024
"The Company has engaged and is working diligently with a series of professionals to find a path forward in these highly challenging circumstances. We expect to release transparent information about our progress in the near future once cleared to do so by counsel."
says Neilank K. Jha, MD, Executive Chairman & CEO.
'The Company anticipates that its future plan will restore and enhance shareholder value.'
https://www.accesswire.com/864007/historical-regulatory-filing-deficiences-continue-to-stifle-psycheceutical-biosciences
AI
